Chen Q, Miller LJ, and Dong M
Safe use of GLP-1 therapy hinges on close medical supervision and frequent kidney function tests
The bottom line is that Ozempic face is real, but the phrase oversimplifies the biology
Exenatide immediate-release (Byetta): Initiation involves a 5 mcg dose administered subcutaneously twice daily, which can be increased to 10 mcg twice daily after a month if required
GLP-1 receptor agonists enhance glucose-dependent insulin secretion, meaning they help your pancreas release more insulin when blood sugar rises after meals
GLP-1 drugs for heart health Trulicity (dulaglutide) was approved in 2020 for individuals with type 2 diabetes, with or without a history of heart disease, to help reduce the risk of serious cardiovascular events, like heart attacks